Comparison of Some Clinical, Hematological and Serological Parameters According to the Level of Disease Activity in Patients with Rheumatoid Arthritis
DOI:
https://doi.org/10.46966/msjar.v5i2.180Keywords:
Rheumatoid Arthritis (RA), Disease Activity Index, DAS-28 ESR, DAS-28 CRP.Abstract
Objective: This study aimed to evaluate the usefulness of some clinical, hematological, and serological parameters in monitoring of RA activity. Methods: This study included 107 RA patients [98 females and 9 males; mean age 46.85 years (range 18–70)]. The patients were classified into four groups based on their disease activity scores. Disease activity scores (DAS-28 ESR and DAS-28 CRP), complete blood count (CBC), erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), rheumatoid factor (RF), and anti-citrullinated peptide antibody (ACPA) were measured. Results: Both “DAS-28 ESR and DAS-28 CRP” showed a significant difference among the four disease activity groups regarding family history, disease duration, regularity of treatment intake, response to treatment, and ESR level (P> 0.05). Furthermore, DAS-28 CRP revealed a significant difference (P = 0.021) in the CRP levels across the four disease activity groups. Conclusion: The study found an association between some clinical, hematological, and serological factors and the level of disease activity in patients with RA.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Mays Saleh Khamees, Raad Abdulameer Alasady
This work is licensed under a Creative Commons Attribution 4.0 International License.
In submitting the manuscript to the Medical Science Journal for Advance Research, the authors certify that:
- They are authorized by their co-authors to enter into these arrangements.
- The work described has not been formally published before, except in the form of an abstract or as part of a published lecture, review, thesis, or overlay journal.
- That it is not under consideration for publication elsewhere,
- The publication has been approved by the author(s) and by responsible authorities – tacitly or explicitly – of the institutes where the work has been carried out.
- They secure the right to reproduce any material that has already been published or copyrighted elsewhere.
- They agree to the following license and copyright agreement.
License and Copyright Agreement
Authors who publish with Medical Science Journal for Advance Research agree to the following terms:
- Authors retain copyright and grant the Medical Science Journal for Advance Research right of first publication with the work simultaneously licensed under Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the Medical Science Journal for Advance Research published version of the work (e.g., post it to an institutional repository or edit it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
